Publications

  1. Nagelschneider AA, Broski SM, Holland WP, Midthun DE, Sykes AM, Lowe VJ, Peller PJ, Johnson GB. The flip-flop fungus sign: an FDG PET/CT sign of benignity. Am J Nucl Med Mol Imaging. 2017; 7 (5):212-217 Epub 2017 Nov 01
    View PubMed
  2. Martin-Macintosh EL, Broski SM, Johnson GB, Hunt CH, Cullen EL, Peller PJ. Multimodality Imaging of Neurodegenerative Processes: Part 2, Atypical Dementias. AJR Am J Roentgenol. 2016 Aug 9; 1-13.
    View PubMed
  3. Martin-Macintosh EL, Broski SM, Johnson GB, Hunt CH, Cullen EL, Peller PJ. Multimodality Imaging of Neurodegenerative Processes: Part 1, The Basics and Common Dementias. AJR Am J Roentgenol. 2016 Aug 9; 1-12.
    View PubMed
  4. White ML, Johnson GB, Howe BM, Peller PJ, Broski SM. Spectrum of Benign Articular and Periarticular Findings at FDG PETCT. Radiographics. 2016 May-Jun; 36: (3)824-39.
    View PubMed
  5. Welle CL, Cullen EL, Peller PJ, Lowe VJ, Murphy RC, Johnson GB, Binkovitz LA. (1)(1)C-Choline PETCT in Recurrent Prostate Cancer and Nonprostatic Neoplastic Processes. Radiographics. 2016 Jan-Feb; 36: (1)279-92.
    View PubMed
  6. Ma DJ, Galanis E, Anderson SK, Schiff D, Kaufmann TJ, Peller PJ, Giannini C, Brown PD, Uhm JH, McGraw S, Jaeckle KA, Flynn PJ, Ligon KL, Buckner JC, Sarkaria JN. A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K. Neuro Oncol. 2015 Sep; 17 (9):1261-9 Epub 2014 Dec 18
    View PubMed
  7. Lehman VT, Barrick BJ, Pittelkow MR, Peller PJ, Camilleri MJ, Lehman JS. Diagnostic imaging in paraneoplastic autoimmune multiorgan syndrome: retrospective single site study and literature review of 225 patients. Int J Dermatol. 2015 Apr; 54: (4)424-37.
    View PubMed
  8. Ferraro R, Agarwal A, Martin-Macintosh EL, Peller PJ, Subramaniam RM. MR imaging and PET/CT in diagnosis and management of multiple myeloma. Radiographics. 2015 Mar-Apr; 35: (2)438-54.
    View PubMed
  9. Johnson GB, Peller PJ, Kemp BJ, Ryu JH. Future of thoracic PET scanning. Chest. 2015 Jan; 147: (1)25-30.
    View PubMed
  10. Crush AB, Howe BM, Spinner RJ, Amrami KK, Hunt CH, Johnson GB, Murphy RC, Morreale RF, Peller PJ. Malignant involvement of the peripheral nervous system in patients with cancer: multimodality imaging and pathologic correlation. Radiographics. 2014 Nov-Dec; 34(7):1987-2007.
    View PubMed
  11. Broski SM, Hunt CH, Johnson GB, Morreale RF, Lowe VJ, Peller PJ. Structural and functional imaging in parkinsonian syndromes. Radiographics. 2014 Sep-Oct; 34: (5)1273-92.
    View PubMed
  12. Surasi DS, Peller PJ, Szabo Z, Mercier G, Subramaniam RM. Dopamine Transporter SPECT Imaging in Parkinson Disease and Dementia. PET Clin. 2013 Oct; 8: (4)459-67.
    View PubMed
  13. Peller PJ. Role of positron emission tomography/computed tomography in bone malignancies. Radiol Clin North Am. 2013 Sep; 51: (5)845-64.
    View PubMed
  14. Lowe VJ, Peller PJ, Weigand SD, Montoya Quintero C, Tosakulwong N, Vemuri P, Senjem ML, Jordan L, Jack CR Jr, Knopman D, Petersen RC. Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI. Neurology. 2013 Jun 04; 80: (23)2130-7.
    View PubMed
  15. Clapp AJ, Hunt CH, Johnson GB, Peller PJ. Semiquantitative analysis of brain metabolism in patients with paraneoplastic neurologic syndromes. Clin Nucl Med. 2013 Apr; 38: (4)241-7.
    View PubMed
  16. Dibble EH, Karantanis D, Mercier G, Peller PJ, Kachnic LA, Subramaniam RM. PET/CT of cancer patients: part 1, pancreatic neoplasms. AJR Am J Roentgenol. 2012 Nov; 199(5):952-67.
    View PubMed
  17. Broski SM, Hunt CH, Johnson GB, Subramaniam RM, Peller PJ. The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma. J Nucl Med. 2012 Aug; 53: (8)1200-6.
    View PubMed
  18. Lehman VT, Carter RE, Claassen DO, Murphy RC, Lowe V, Petersen RC, Peller PJ. Visual assessment versus quantitative three-dimensional stereotactic surface projection fluorodeoxyglucose positron emission tomography for detection of mild cognitive impairment and Alzheimer disease. Clin Nucl Med. 2012 Aug; 37: (8)721-6.
    View PubMed
  19. Onkendi EO, Richards ML, Thompson GB, Farley DR, Peller PJ, Grant CS. Thyroid cancer detection with dual-isotope parathyroid scintigraphy in primary hyperparathyroidism. Ann Surg Oncol. 2012 May; 19 (5):1446-52 Epub 2012 Mar 07
    View PubMed
  20. McDade E, Boeve BF, Burrus TM, Boot BP, Kantarci K, Fields J, Lowe VJ, Peller P, Knopman D, Baker M, Finch N, Rademakers R, Petersen R. Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin. Neurology. 2012 Apr 17; 78: (16)1245-9.
    View PubMed
  21. Chandler KJ, Hunt CH, Morreale R, Johnson GB, Peller PJ. Effect of patient age, breast density, and topical anesthetic cream on perceived pain with sentinel lymph node scintigraphy. J Nucl Med Technol. 2012 Mar; 40: (1)44-7.
    View PubMed
  22. Lingle WL, Negron V, Johnson GB, Nathan MA, Parasi JE, Johnson AJ, Hunt CH, Peller PJ, Broski SM, Fauq AH, Jack CR, Petersen RC, Klunk WE, Mathis CA, Lowe V. Adapting a pet imaging agent for correlative microscopy of meningiomas and other intracranial tumors Microscopy and Microanalysis. 2012; 18:178-9.
  23. Sarkaria JN, Galanis E, Wu W, Peller PJ, Giannini C, Brown PD, Uhm JH, McGraw S, Jaeckle KA, Buckner JC. North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2011 Oct 01; 81: (2)468-75.
    View PubMed
  24. Davison JM, Subramaniam RM, Surasi DS, Cooley T, Mercier G, Peller PJ. FDG PET/CT in patients with HIV. AJR Am J Roentgenol. 2011 Aug; 197(2):284-94.
    View PubMed
  25. Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. Value of PET/CT in the management of liver metastases, part 1. AJR Am J Roentgenol. 2011 Aug; 197(2):W256-9.
    View PubMed
  26. Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. Value of PET/CT in the management of primary hepatobiliary tumors, part 2. AJR Am J Roentgenol. 2011 Aug; 197(2):W260-5.
    View PubMed
  27. Johnson GB, Peller PJ, Bahrami A, Subramaniam RM. AJR teaching file: left neck mass evaluated by PET/CT. AJR Am J Roentgenol. 2011 Jun; 196: (6 Suppl)WS78-82.
    View PubMed
  28. Clapp AJ, Peller PJ, Subramaniam RM. AJR teaching file: incidental breast cancer detected with 18F-FDG PET/CT. AJR Am J Roentgenol. 2011 Jun; 196: (6 Suppl)WS83-5.
    View PubMed
  29. Murphy RC, Kawashima A, Peller PJ. The utility of 11C-choline PET/CT for imaging prostate cancer: a pictorial guide. AJR Am J Roentgenol. 2011 Jun; 196: (6)1390-8.
    View PubMed
  30. Sarkaria JN, Peller PJ, Galanis E, Jacobson MS, Wu W, Jaeckle KA, Buckner JC. FLT-PET analysis of early response to everolimus in newly diagnosed glioblastoma patients enrolled on NCCTG N057K. J Clin Oncol. 2011 May 20; 29: (15_suppl)e12501.
    View PubMed
  31. Claassen DO, Lowe VJ, Peller PJ, Petersen RC, Josephs KA. Amyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy. Parkinsonism Relat Disord. 2011 Mar; 17(3):160-5. Epub 2010 Dec 31.
    View PubMed
  32. Josephs KA, Duffy JR, Fossett TR, Strand EA, Claassen DO, Whitwell JL, Peller PJ. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants. Arch Neurol. 2010 May; 67: (5)596-605.
    View PubMed
  33. Subramaniam RM, Truong M, Peller P, Sakai O, Mercier G. Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. AJNR Am J Neuroradiol. 2010 Apr; 31(4):598-604. Epub 2009 Nov 12.
    View PubMed
  34. Claassen DO, Josephs KA, Peller PJ. The stripe of primary lateral sclerosis: focal primary motor cortex hypometabolism seen on fluorodeoxyglucose F18 positron emission tomography. Arch Neurol. 2010 Jan; 67: (1)122-5.
    View PubMed
  35. Wilcox BE, Subramaniam RM, Peller PJ, Aughenbaugh GL, Nichols Iii FC, Aubry MC, Jett JR. Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma. Clin Lung Cancer. 2009 Jul; 10: (4)244-8.
    View PubMed
  36. Yu CH, Peller PJ, Subramaniam R. F-18 FDG PET/CT imaging of intraventricular germinoma. Clin Nucl Med. 2009 Jun; 34(6):393-4.
    View PubMed
  37. Subramaniam RM, Wilcox B, Aubry MC, Jett J, Peller PJ. 18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma. J Med Imaging Radiat Oncol. 2009 Apr; 53: (2)160-9; quiz 170.
    View PubMed
  38. Jones K, Subramaniam RM, Durnick DK, Peller PJ. F-18-FDG-PET/CT imaging of small cell carcinoma of the colon. Clin Nucl Med. 2008 Sep; 33: (9)645-6.
    View PubMed
  39. Subramaniam RM, Durnick DK, Peller PJ. F-18 FDG PET/CT imaging of submandibular gland oncocytoma. Clin Nucl Med. 2008 Jul; 33: (7)472-4.
    View PubMed
  40. Subramaniam RM, Mandrekar J, Chang C, Blair D, Gilbert K, Peller PJ, Sleigh J, Karalus N. Pulmonary embolism outcome: a prospective evaluation of CT pulmonary angiographic clot burden score and ECG score. AJR Am J Roentgenol. 2008 Jun; 190(6):1599-604.
    View PubMed
  41. Karantanis D, Subramaniam RM, Peller PJ, Lowe VJ, Durski JM, Collins DA, Georgiou E, Ansell SM, Wiseman GA. The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma. Clin Lymphoma Myeloma. 2008 Apr; 8: (2)94-9.
    View PubMed
  42. Karantanis D, O'eill BP, O'Neill BP, Subramaniam RM, Witte RJ, Mullan BP, Nathan MA, Lowe VJ, Peller PJ, Wiseman GA. 18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients. Nucl Med Commun. 2007 Nov; 28: (11)834-41.
    View PubMed
  43. Subramaniam RM, Karantanis D, Peller PJ. [18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism. J Comput Assist Tomogr. 2007 Sep-Oct; 31: (5)770-2.
    View PubMed
  44. Karantanis D, Subramaniam RM, Mullan BP, Peller PJ, Wiseman GA. Focal F-18 fluoro-deoxy-glucose accumulation in the lung parenchyma in the absence of CT abnormality in PET/CT. J Comput Assist Tomogr. 2007 Sep-Oct; 31: (5)800-5.
    View PubMed
  45. Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM, Nathan MA, Peller PJ, Bahn RS, Lowe VJ. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med. 2007 Jun; 48: (6)896-901.
    View PubMed
  46. Karantanis D, O'Neill BP, Subramaniam RM, Peller PJ, Witte RJ, Mullan BP, Wiseman GA. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma. Clin Nucl Med. 2007 Apr; 32(4):271-4.
    View PubMed
  47. Khalkhali I, Diggles LE, Taillefer R, Vandestreek PR, Peller PJ, Abdel-Nabi HH. Procedure guidelines for breast scintigraphy. J Nucl Med. 1999; 40:1233-5.
    View PubMed
  48. Khedkar NY, Gavilan-Agpoon T, Redden R, Peller P, Lakier J. Role of duplex imaging in intermediate category ventilation perfusion scans. JDMS. 1998; 14:113-5.
  49. Sharifi M, Khedkar NY, Peller PJ, Martinez CJ, Sorkin R, Lakier J. First pass technetium sestamibi ventriculography in the assessment of left ventricular diastolic dysfunction: a comparison with Doppler echocardiography. Clin Nucl Med. 1996; 21:679-84.
    View PubMed
  50. Peller PJ, Khedkar NY, Martinez CJ. Breast tumor scintigraphy. J Nucl Med Technol. 1996; 24:198-203.
  51. Arne ET, Khedkar NY, Peller PJ, Martinez CJ, Buckman J, Walat L, Lakier JB. Imaging of a common carotid artery dissection with Doppler color flow - a case report. J Vasc Tech. 1995; 19:75-7.
  52. Williams SC, Peller PJ. Gardner's syndrome. Case report and discussion of the manifestations of the disorder. Clin Nucl Med. 1994 Aug; 19(8):668-70.
    View PubMed
  53. Perusse KR, McAdams HP, Earls JP, Peller PJ. General case of the day. Post traumatic thoracic lymphocele. Radiographics. 1994; 14:192-5.
    View PubMed
  54. Peller PJ, Khedkar N, Martinez C. Transient renal hypotension during a vasovagal episode. J Nucl Med Technol. 1994; 22:63-4.
  55. Coccaro G, Khedkar NY, Peller PJ, Martinez J. An early false negative bone scan in a spiral fracture. Clin Nucl Med. 1994; 19:818-9.
    View PubMed
  56. Peller PJ, Ho VB, Kransdorf MJ. Extraosseous Tc-99m MDP uptake: a pathophysiologic approach. Radiographics. 1993 Jul; 13(4):715-34.
    View PubMed
  57. Szabo Z, Ravert HT, Gozukara I, Geckle W, Seki C, Sostre S, Peller P, Monsen L, Natarajan TR, Links JM. Noncompartmental and compartmental modeling of the kinetics of carbon-11 labeled pyrilamine in the human brain. Synapse. 1993; 15:263-75.
    View PubMed
  58. Peller PJ, Anderson JH. Transient diaphyseal tibial Tc-99m MDP uptake and bone marrow edema in acute rheumatic fever. Clin Nucl Med. 1992 Aug; 17(8):634-7.
    View PubMed
  59. Murphy JR, Peller PJ, McNally P, Shay SS. Prolonged clearance is the predominant abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis. Dig Dis Sci. 1992; 37:833-41.
    View PubMed
  60. Jelinek JS, Redmond J 3rd, Perry JJ, Burrell LM, Benedikt RA, Geyer CA, Peller PJ, Wacks LL, Wise BJ, Ghaed VN. Small cell lung cancer: staging with MR imaging. Radiology. 1990 Dec; 177(3):837-42.
    View PubMed